Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 576,300 | 404,000 | 447,700 | 548,000 | 621,500 |
| Receivables | 274,700 | 254,600 | 261,900 | 184,400 | 230,900 |
| Inventories | 350,800 | 364,600 | 386,400 | 406,500 | 307,000 |
| TOTAL | $1,272,100 | $1,111,500 | $1,162,100 | $1,181,100 | $1,195,900 |
| Non-Current Assets | |||||
| PPE Net | 800,100 | 768,700 | 743,500 | 692,900 | 644,100 |
| Intangibles | 829,500 | 885,100 | 899,700 | 914,700 | 929,800 |
| Other Non-Current Assets | 57,300 | 102,200 | 109,900 | 111,400 | 113,400 |
| TOTAL | $1,686,900 | $1,756,000 | $1,753,100 | $1,719,000 | $1,687,300 |
| Total Assets | $2,959,000 | $2,867,500 | $2,915,200 | $2,900,100 | $2,883,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,600 | 31,600 | 28,800 | 26,000 | N/A |
| Accounts payable and accrued liabilities | 128,900 | 135,200 | 151,800 | 142,200 | 136,100 |
| Accrued Expenses | 140,400 | 116,300 | 97,000 | 80,000 | 131,500 |
| Other current liabilities | 72,900 | 82,300 | 100,200 | 122,000 | 116,900 |
| TOTAL | $373,800 | $365,400 | $377,800 | $370,200 | $384,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 809,400 | 817,300 | 825,200 | 833,100 | 841,000 |
| Other Non-Current Liabilities | 61,900 | 109,100 | 115,300 | 120,700 | 157,500 |
| TOTAL | $966,200 | $979,400 | $993,700 | $1,007,100 | $1,051,700 |
| Total Liabilities | $1,340,000 | $1,344,800 | $1,371,500 | $1,377,300 | $1,436,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,501 | 53,799 | 53,701 | 53,585 | 53,300 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 957,800 | 768,500 | N/A | 796,600 | 726,900 |
| Other shareholders' equity | -16,300 | -22,700 | 779,200 | -24,000 | -24,900 |
| TOTAL | $1,619,000 | $1,522,700 | $1,543,700 | $1,522,800 | $1,447,000 |
| Total Liabilities And Equity | $2,959,000 | $2,867,500 | $2,915,200 | $2,900,100 | $2,883,200 |